Healthcare provider profile · identity verified

Thomas Savinelli, MD

Internal Medicine · WETHERSFIELD, CT · NPI 1821193343

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1194	351
Rosuvastatin Calcium	Rosuvastatin Calcium	1126	324
Amlodipine Besylate	Amlodipine Besylate	830	239
Levothyroxine Sodium	Levothyroxine Sodium	825	229
Lisinopril	Lisinopril	733	204
Valsartan	Valsartan	499	146
Metformin Hcl	Metformin Hcl	448	148
Metoprolol Succinate	Metoprolol Succinate	361	104
Losartan Potassium	Losartan Potassium	328	90
Omeprazole	Omeprazole	318	97
Allopurinol	Allopurinol	282	83
Escitalopram Oxalate	Escitalopram Oxalate	264	73
Hydrochlorothiazide	Hydrochlorothiazide	264	85
Gabapentin	Gabapentin	252	62
Pravastatin Sodium	Pravastatin Sodium	244	60
Alendronate Sodium	Alendronate Sodium	237	66
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	230	64
Chlorthalidone	Chlorthalidone	225	64
Montelukast Sodium	Montelukast Sodium	209	57
Albuterol Sulfate Hfa	Albuterol Sulfate	194	83
Simvastatin	Simvastatin	182	57
Pantoprazole Sodium	Pantoprazole Sodium	177	54
Atenolol	Atenolol	168	49
Jardiance	Empagliflozin	163	55
Tamsulosin Hcl	Tamsulosin Hcl	163	48
Duloxetine Hcl	Duloxetine Hcl	161	46
Metformin Hcl Er	Metformin Hcl	159	47
Eliquis	Apixaban	157	44
Famotidine	Famotidine	155	47
Furosemide	Furosemide	145	44
Synthroid	Levothyroxine Sodium	137	46
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	125	39
Fluticasone Propionate	Fluticasone Propionate	120	43
Trazodone Hcl	Trazodone Hcl	119	42
Carvedilol	Carvedilol	111	33
Ezetimibe	Ezetimibe	111	35
Sertraline Hcl	Sertraline Hcl	108	26
Potassium Chloride	Potassium Chloride	106	31
Finasteride	Finasteride	100	32
Telmisartan	Telmisartan	96	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	26
Metoprolol Tartrate	Metoprolol Tartrate	80	30
Olmesartan Medoxomil	Olmesartan Medoxomil	79	23
Bupropion Xl	Bupropion Hcl	71	23
Glimepiride	Glimepiride	71	23
Ozempic	Semaglutide	68	18
Lansoprazole	Lansoprazole	67	20
Nebivolol Hcl	Nebivolol Hcl	62	16
Meloxicam	Meloxicam	61	19
Fluoxetine Hcl	Fluoxetine Hcl	60	15
Mirtazapine	Mirtazapine	60	21
Donepezil Hcl	Donepezil Hcl	59	17
Trulicity	Dulaglutide	59	11
Esomeprazole Magnesium	Esomeprazole Magnesium	56	18
Hydroxyzine Hcl	Hydroxyzine Hcl	56	23
Lovastatin	Lovastatin	55	14
Spironolactone	Spironolactone	55	18
Irbesartan	Irbesartan	53	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	49	13
Citalopram Hbr	Citalopram Hydrobromide	45	13
Fenofibrate	Fenofibrate	45	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	43	18
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	43	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	42	14
Xarelto	Rivaroxaban	42	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	38
Januvia	Sitagliptin Phosphate	40	12
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Valacyclovir	Valacyclovir Hcl	38	15
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	36	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	36	12
Raloxifene Hcl	Raloxifene Hcl	35	11
Memantine Hcl	Memantine Hcl	34	suppressed
Tradjenta	Linagliptin	34	suppressed
Benazepril Hcl	Benazepril Hcl	33	11
Clopidogrel	Clopidogrel Bisulfate	33	11
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	12
Venlafaxine Hcl Er	Venlafaxine Hcl	32	11
Farxiga	Dapagliflozin Propanediol	31	suppressed
Mounjaro	Tirzepatide	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Ramipril	Ramipril	27	suppressed
Prednisone	Prednisone	26	12
Colchicine	Colchicine	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Nystatin	Nystatin	24	11
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Dexlansoprazole Dr	Dexlansoprazole	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Letrozole	Letrozole	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Dutasteride	Dutasteride	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Icosapent Ethyl	Icosapent Ethyl	17	suppressed
Torsemide	Torsemide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Epinephrine	Epinephrine	16	14
Folic Acid	Folic Acid	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Digoxin	Digoxin	14	suppressed
Nystop	Nystatin	14	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	14	suppressed
Risedronate Sodium	Risedronate Sodium	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Bystolic	Nebivolol Hcl	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Linzess	Linaclotide	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Diclofenac Epolamine	Diclofenac Epolamine	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	12	suppressed
Risperidone	Risperidone	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error